$103.35
1.60% yesterday
Nasdaq, Oct 29, 09:00 pm CET
ISIN
US09075V1026
Symbol
BNTX

BioNTech SE - ADR Stock News

Neutral
GlobeNewsWire
one day ago
MAINZ, Germany, October 28 , 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), will host an edition of the Company's Innovation Series R&D Day at 09:00 a.m. Eastern Standard Time (3:00 p.m. CET) on Tuesday, November 11, 2025 in New York City, U.S.
Neutral
GlobeNewsWire
3 days ago
MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2025 on Monday, November 3, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EST (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial result...
Neutral
GlobeNewsWire
8 days ago
MAINZ, Germany, October 22, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced it had commenced its public exchange offer (the “Offer”) for all outstanding shares of CureVac N.V. (Nasdaq: CVAC, “CureVac”). The Offer is being made pursuant to the previously announced purchase agreement between BioNTech and CureVac, dated as of June 12, 2025 (the “Purchase Agreement”)...
Neutral
Seeking Alpha
12 days ago
Moderna and BioNTech were the main 'saviors' of people and economies from COVID-19. However, since the pandemic ended, their stock prices have fallen by more than 70%. Recognizing this, BioNTech and Moderna continue to actively diversify their portfolios of experimental drugs and vaccines toward cancer treatment.
AD HOC NEWS
12 days ago
Europa bringt erfolgreiche Unternehmen hervor, doch oft ziehen sie die USA für einen Börsengang vor - wie der Mainzer Impfstoffentwickler Biontech US09075V1026 oder der Bezahldienst Klarna GB00BMHVL512.
Neutral
The Motley Fool
22 days ago
On Sept. 30, Pfizer announced a deal with the U.S. government that will allow the pharmaceutical leader to avoid President Donald Trump's tariffs for three years in exchange for slashing the prices of certain drugs in the U.S. and investing in local manufacturing efforts. This deal lifted not only Pfizer, but also much of the healthcare sector, especially the company's drugmaking peers, as Wall...
Neutral
Seeking Alpha
28 days ago
BioNTech SE, InstaDeep Ltd - Special Call Company Participants Ugur Sahin - Co-Founder, CEO & Chair of the Management Board Karim Beguir Alexandre Laterre Bernardo Almeida Bora Guloglu Nicolas Lopez Carranza Youssef Ben Dhieb Cheng Zhang Antoine Delaunay Conference Call Participants Lexi Walls Michael Rooney Michael Pye - Baillie Gifford Overseas Limited Presentation Unknown Executive Hi. Good ...
Positive
The Motley Fool
28 days ago
Germany-based BioNTech (BNTX 3.64%) saw its U.S. listed stock enjoy a mini-pop on Wednesday, and for once this wasn't largely based on the Comirnaty COVID-19 vaccine it developed with Pfizer. Rather, investors seemed to be cheered by the biotech's continuing efforts to harness artificial intelligence (AI) technology.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today